EISAI INC. for EISAI INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Biosimilars, Patent Reform HR 1260, Patent Reform Act of 2009 S. 515, Patent Reform Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAYMOND FROST New | — |
| STEPHEN D MCMILLAN | — |
| PETER NORMAN | — |
Medicare/Medicaid MMM
Health Reform, Comparative Effectiveness, Medicare "non-interference," Alzheimer's Awareness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAYMOND FROST New | — |
| STEPHEN D MCMILLAN | — |
| PETER NORMAN | — |
Health Issues HCR
Health Reform, Comparative Effectiveness, Alzheimer's Awareness H.R. 1, American Recovery and Reinvestment Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAYMOND FROST New | — |
| STEPHEN D MCMILLAN | — |
| PETER NORMAN | — |
Pharmacy PHA
HR 1427, Promoting Innovation and Access to Life-Saving Medicine Act HR 1548, Pathway for Biosimilars Act of 2009 S. 726, Promoting Innovation and Access to Life-Saving Medicine Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAYMOND FROST New | — |
| STEPHEN D MCMILLAN | — |
| PETER NORMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.